000 | 01910 a2200529 4500 | ||
---|---|---|---|
005 | 20250514063402.0 | ||
264 | 0 | _c20030417 | |
008 | 200304s 0 0 eng d | ||
022 | _a0002-9149 | ||
024 | 7 |
_a10.1016/s0002-9149(02)03375-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNaccarelli, Gerald V | |
245 | 0 | 0 |
_aOld and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. _h[electronic resource] |
260 |
_bThe American journal of cardiology _cMar 2003 |
||
300 |
_a15D-26D p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAmiodarone _xtherapeutic use |
650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xadverse effects |
650 | 0 | 4 |
_aAtrial Fibrillation _xdrug therapy |
650 | 0 | 4 | _aAustralia |
650 | 0 | 4 | _aCanada |
650 | 0 | 4 | _aControlled Clinical Trials as Topic |
650 | 0 | 4 | _aEurope |
650 | 0 | 4 |
_aFlecainide _xtherapeutic use |
650 | 0 | 4 |
_aHeart Conduction System _xdrug effects |
650 | 0 | 4 |
_aHeart Failure _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMulticenter Studies as Topic |
650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
650 | 0 | 4 |
_aPhenethylamines _xtherapeutic use |
650 | 0 | 4 |
_aPropafenone _xtherapeutic use |
650 | 0 | 4 |
_aQuinidine _xtherapeutic use |
650 | 0 | 4 |
_aSotalol _xtherapeutic use |
650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTherapeutic Equivalency |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aWolbrette, Deborah L | |
700 | 1 | _aKhan, Mazhar | |
700 | 1 | _aBhatta, Luna | |
700 | 1 | _aHynes, John | |
700 | 1 | _aSamii, Soraya | |
700 | 1 | _aLuck, Jerry | |
773 | 0 |
_tThe American journal of cardiology _gvol. 91 _gno. 6A _gp. 15D-26D |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9149(02)03375-1 _zAvailable from publisher's website |
999 |
_c12463711 _d12463711 |